Showing results (51-60 of 99) with videos related to
Sort By:
Pageof 10
Open Forum Infectious Diseases|February 28, 2020
Frequency of Potential Drug-Drug Interactions in the Changing Field of HCV TherapyBenjamin Schulte, Maximilian Wübbolding, Fiona Marra, et al.British Journal of Clinical Pharmacology|October 25, 2025
Human vs. artificial intelligence: Physicians outperform ChatGPT in real-world pharmacotherapy counsellingBenjamin Krichevsky, Stefan Engeli, Stefanie M Bode-Böger, et al.Journal of Neural Transmission (Vienna, Austria : 1996)|September 1, 2022
Potentially inappropriate medications according to PRISCUS list and FORTA (Fit fOR The Aged) classification in geriatric psychiatry: a cross-sectional studyMartin Schulze Westhoff, Adrian Groh, Sebastian Schröder, et al.Frontiers in Cardiovascular Medicine|June 19, 2026
Early escalation of oral lipid-lowering therapy to achieve LDL-cholesterol targets in patients after myocardial infarction: study protocol for the prospective, open-label HAnnover ChOlesterol Lowering in Acute Coronary Syndrome trialAndreas Schäfer, Anika Großhennig, Leonie Theis, et al.International Journal of Geriatric Psychiatry|August 25, 2022
Medication-related problems in geriatric psychiatry-a retrospective cohort studyJohannes Heck, Christian Ihlefeld, Olaf Krause, et al.Irish Journal of Medical Science|February 22, 2023
Adverse drug reactions in geriatric psychiatry-retrospective cohort study of a 6-year periodJohannes Heck, Nina Noltemeyer, Martin Schulze Westhoff, et al.European Journal of Clinical Pharmacology|December 8, 2022
Duplicate prescriptions in the emergency department: a retrospective cohort studyJohannes Heck, Benjamin Krichevsky, Adrian Groh, et al.Naunyn-Schmiedeberg'S Archives of Pharmacology|July 22, 2026
Clinical-pharmacological medication reviews for insurants of a German statutory health insurance fund (Kaufmännische Krankenkasse (KKH)): a 5-year retrospective analysis (2019-2023)Johannes Heck, Dirk O Stichtenoth, Lutz Herbarth, et al.Biology Open|July 27, 2018
Cell tracking in vitro reveals that the extracellular matrix glycoprotein Tenascin-C modulates cell cycle length and differentiation in neural stem/progenitor cells of the developing mouse spinal cordMarcus May, Bernd Denecke, Timm Schroeder, et al.Neuroimmunomodulation|October 5, 2021
The Central Inflammatory Network: A Hypothalamic fMRI Study of Experimental Endotoxemia in HumansNatalia Färber, Jorge Manuel, Marcus May, et al.Pageof 10